Suivre
Dhiraj Kumar, PhD
Dhiraj Kumar, PhD
Columbia University Irving Medical Center, New York, USA
Adresse e-mail validée de cumc.columbia.edu
Titre
Citée par
Citée par
Année
Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges
DKGCK Ramesh Butti, Sumit Das, Vinoth Prasanna Gunasekaran, Amit Singh Yadav
Molecular Cancer 17 (34), 2018
3022018
MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2
A Ghosh, D Dasgupta, A Ghosh, S Roychoudhury, D Kumar, M Gorain, ...
Cell death & disease 8 (3), e2706-e2706, 2017
1552017
Osteopontin as a therapeutic target for cancer
M Bandopadhyay, A Bulbule, R Butti, G Chakraborty, P Ghorpade, ...
Expert opinion on therapeutic targets 18 (8), 883-895, 2014
1442014
Ascochlorin enhances the sensitivity of doxorubicin leading to the reversal of epithelial-to-mesenchymal transition in hepatocellular carcinoma
X Dai, KS Ahn, LZ Wang, C Kim, A Deivasigamni, F Arfuso, JY Um, ...
Molecular Cancer Therapeutics 15 (12), 2966-2976, 2016
862016
Osteopontin: a potentially important therapeutic target in cancer
M Ahmed, R Behera, G Chakraborty, S Jain, V Kumar, P Sharma, ...
Expert opinion on therapeutic targets 15 (9), 1113-1126, 2011
862011
Andrographolide Inhibits Osteopontin Expression and Breast Tumor Growth Through Down Regulation of PI3 Kinase/Akt Signaling Pathway
S Kumar, H S. Patil, P Sharma, D Kumar, S Dasari, V G. Puranik, ...
Current Molecular Medicine 16 (8), 952-966, 2012
842012
Non-coding RNAs as potential therapeutic targets in breast cancer
D Tomar, AS Yadav, D Kumar, G Bhadauriya, GC Kundu
Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1863 (4), 194378, 2020
772020
Notch1-MAPK signaling axis regulates CD133+ cancer stem cell-mediated melanoma growth and angiogenesis
D Kumar, S Kumar, M Gorain, D Tomar, HS Patil, NNV Radharani, ...
Journal of Investigative Dermatology 136 (12), 2462-2474, 2016
752016
Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma
D Kumar, M Gorain, G Kundu, GC Kundu
Molecular cancer 16, 1-18, 2017
682017
Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway
D Kumar, S Haldar, M Gorain, S Kumar, FA Mulani, AS Yadav, L Miele, ...
BMC cancer 18, 1-17, 2018
622018
Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway
NNV Radharani, AS Yadav, R Nimma, TVS Kumar, A Bulbule, ...
Cancer cell international 22 (1), 122, 2022
602022
The biology and therapeutic implications of tumor dormancy and reactivation
AS Yadav, PR Pandey, R Butti, NNV Radharani, S Roy, SR Bhalara, ...
Frontiers in oncology 8, 72, 2018
572018
Functional characterization of stromal osteopontin in melanoma progression and metastasis
S Kumar, P Sharma, D Kumar, G Chakraborty, M Gorain, GC Kundu
PloS one 8 (7), e69116, 2013
552013
Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma
N Jain, K Hartert, S Tadros, W Fiskus, O Havranek, MCJ Ma, A Bouska, ...
Science translational medicine 11 (497), eaav5599, 2019
542019
RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics
PR Pandey, KH Young, D Kumar, N Jain
Molecular cancer 21 (1), 58, 2022
422022
Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression
R Butti, R Nimma, G Kundu, A Bulbule, TVS Kumar, VP Gunasekaran, ...
Oncogene 40 (11), 2002-2017, 2021
372021
Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis
H Han, Y Wang, J Curto, S Gurrapu, S Laudato, A Rumandla, ...
Cell reports 39 (1), 2022
282022
The potential of class 3 semaphorins as both targets and therapeutics in cancer
R Mishra, D Kumar, D Tomar, G Chakraborty, S Kumar, GC Kundu
Expert Opinion on Therapeutic Targets 19 (3), 427-442, 2015
182015
Noncoding RNAs: biology and applications—a Keystone Symposia report
J Cable, E Heard, T Hirose, KV Prasanth, LL Chen, JE Henninger, ...
Annals of the new York Academy of Sciences 1506 (1), 118-141, 2021
142021
One-pot fluorescent labeling protocol for complex hydroxylated bioactive natural products
S Haldar, S Kumar, SP Kolet, HS Patil, D Kumar, GC Kundu, ...
The Journal of Organic Chemistry 78 (20), 10192-10202, 2013
122013
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20